Citadel Advisors
OFIX icon

Citadel Advisors’s Orthofix Medical OFIX Stock Holding History

Citadel Advisors’s Portfolio OFIX Stock Details OFIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-500
Closed -$8.15K – 14318
2025
Q1 		$8.15K Buy
500
+100
+25% +$1.75K ﹤0.01% 13655
2024
Q4 		$6.98K Buy
400
+100
+33% +$1.74K ﹤0.01% 13768
2024
Q3 		$4.69K Sell
300
-300
-50% -$4.81K ﹤0.01% 13547
2024
Q2 		$7.96K Buy
600
+400
+200% +$5.48K ﹤0.01% 13220
2024
Q1 		$2.9K Buy
+200
New +$2.77K ﹤0.01% 13962
2023
Q1 		– Sell
-600
Closed -$12.3K – 15265
2022
Q4 		$12.3K Buy
+600
New +$10.6K ﹤0.01% 13512
2019
Q3 		– Sell
-12,200
Closed -$645K – 9591
2019
Q2 		$645K Sell
12,200
-8,800
-42% -$468K ﹤0.01% 6414
2019
Q1 		$1.19M Buy
21,000
+14,000
+200% +$786K ﹤0.01% 5287
2018
Q4 		$367K Sell
7,000
-4,200
-38% -$239K ﹤0.01% 6916
2018
Q3 		$647K Buy
11,200
+700
+7% +$39.2K ﹤0.01% 6285
2018
Q2 		$597K Sell
10,500
-6,200
-37% -$353K ﹤0.01% 6080
2018
Q1 		$982K Buy
+16,700
New +$935K ﹤0.01% 4833
2015
Q4 		– Sell
-1,400
Closed -$47K – 9041
2015
Q3 		$47K Sell
1,400
-4,100
-75% -$146K ﹤0.01% 7627
2015
Q2 		$182K Buy
5,500
+4,200
+323% +$144K ﹤0.01% 6439
2015
Q1 		$47K Sell
1,300
-500
-28% -$15.7K ﹤0.01% 7417
2014
Q4 		$54K Sell
1,800
-10,400
-85% -$305K ﹤0.01% 7133
2014
Q3 		$378K Buy
12,200
+6,300
+107% +$209K ﹤0.01% 4988
2014
Q2 		$214K Buy
5,900
+3,300
+127% +$107K ﹤0.01% 5490
2014
Q1 		$78K Buy
+2,600
New +$60K ﹤0.01% 6404

Other funds holding OFIX

ECM
Engine Capital Management New York $828M AUM 6.49% 1-Year Est. Return
JIC
Juniper Investment Company New York $313M AUM 79.58% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Citadel Advisors's OFIX Position: Q1 2026 in Review

Citadel Advisors increased its Orthofix Medical (OFIX) stake by 547% in Q1 2026, buying an estimated $1.41M and bringing the position to 126,403 shares worth $1.45M. The position accounts for ﹤0.01% of the portfolio, ranked #6791.

Citadel Advisors first reported a position in OFIX in Q2 2013 and has held it in 47 quarters since. The position peaked at $7.35M in Q4 2018. 147 funds tracked by Wall St. Rank hold OFIX as of Q1 2026.

  • Citadel Advisors held 126,403 shares of Orthofix Medical worth $1.45M as of Q1 2026.
  • Citadel Advisors bought 106,858 Orthofix Medical shares in Q1 2026, an estimated $1.41M.
  • Orthofix Medical made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #6791 holding.
  • Citadel Advisors first reported a position in Orthofix Medical in Q2 2013 and has held it in 47 quarters since.
  • Citadel Advisors's Orthofix Medical position peaked at $7.35M in Q4 2018.
  • 147 funds tracked by Wall St. Rank held Orthofix Medical as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.